12:00 AM
Jan 10, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Intranasal calcitonin: Began Phase II/III trial

Unigene Inc. (UGNE), Fairfield, N.J.
Product: Intranasal calcitonin
Business: Musculoskeletal
Therapeutic category: Drug delivery, Hormone...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >